Translate page

iStock 1203771991 CoronavirusIn this ever changing COVID-19 (coronavirus) pandememic keeping up to date with reliable information is key. In an effort to serve the CML community best during these difficult times, we have created this COVID-19 hub to provide you with expert statements, frequenty asked questions, relevant clinical papers and other reliable ressources.

We will be keeping you updated as more information becomes available.

If you have specific questions or want to share information around COVID-19 and CML that has been particularly helpful to you, please email

Logo EHA

We are delighted to share that a first sub-analysis of the iCMLf CML and COVID-19 CANDID data has been accepted as a clinical poster presentation for the EHA 2022 Congress in June:

COVID-19 in patients with chronic myeloid leukemia in treatment-free remission:
Disease-severity and impact on TFR status (Saußele S et al. EHA 2022 abstract no. 1886)

The sub-analysis of the CANDID study aimed to evaluate the outcome of SARS-CoV-2 infection in CML patients in treatment-free remission and assessed any impact on maintenance of TFR. Additional information were collected for this analysis including: molecular remission status before, during and after COVID-19 infection.

We look forward to seeing you at EHA and sharing more details.

The iCMLf has compiled for you expert talks, frequently asked questions, statements, expert opinions and interesting cases on COVID-19 and CML from reliable sources.

On this section you will find statements, expert talks and frequently asked questions about COVID-19 vaccines and CML.

To help physicians confidently treat people with CML during the pandemic, the iCMLf has collected and analysed COVID-19 cases among patients with CML globally.

With over 1,000 cases reported by >190 physicians from 59 countries the iCMLf CANDID study represents the largest cohort of CML patients with COVID-19 aiming to collect and analyse characteristics of COVID-19 cases among CML patients globally.

The iCMLf is sharing a selection of interesting scientific publications on COVID-19 and CML from peer-reviewed journals.